Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Semaphorin-3G is a secreted member of the class 3 semaphorin protein family, characterized by the presence of a sema domain and functioning primarily as a cell guidance cue in neuronal development and regulation of angiogenesis. SEMA3G binds neuropilin-2 (NRP2) to initiate signaling via associated plexin receptors, affecting vascular and neuronal cell behaviors by regulating migration, proliferation, and cell adhesion. In the vasculature, SEMA3G acts as an autocrine signal for endothelial cells and as a paracrine regulator for smooth muscle cells, with context-dependent pro- or anti-angiogenic activity. Its loss is associated with vascular instability and disease, and it plays additional roles in neural function, adipogenesis, and tumor suppression.
Engages Neuropilin-2 (NRP2) receptor complexes, often with plexin co-receptors, to modulate downstream signaling, affecting cell migration, adhesion, and vascular integrity. Regulates β-catenin stability, thereby protecting endothelial junctions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Semaphorin-3G (SEMA3G).